BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Humacyte Announces Third Quarter 2025 Financial Results and Provides Business Update

  November 13, 2025

   · 

  18 min read
• Press Releases

  Acumen Pharmaceuticals Reports Third Quarter 2025 Financial Results and Business Highlights

  November 13, 2025

   · 

  12 min read
• Press Releases

  BioXcel Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on Late-Stage Clinical Programs for Agitation in Bipolar, Schizophrenia, and Alzheimer’s Disease

  November 13, 2025

   · 

  17 min read
• Press Releases

  BeyondSpring Reports Third‑Quarter 2025 Financial Results and Provides Corporate Update

  November 13, 2025

   · 

  12 min read
• Press Releases

  New Study From GENinCode Shows Polygenic Risk Scores Improve the Accuracy of Cardiovascular Disease Risk Prediction

  November 13, 2025

   · 

  4 min read
• Press Releases

  Biohaven Announces Pricing of $175 Million Public Offering of Common Shares

  November 13, 2025

   · 

  3 min read
• Press Releases

  Acurx Pharmaceuticals, Inc. Reports Third Quarter 2025 Results and Provides Business Update

  November 13, 2025

   · 

  11 min read
• Press Releases

  Basking Biosciences Announces First Participants Dosed in Phase 1 Study of BB-025, a Direct-Acting Reversal Agent for Investigational Stroke Therapy BB-031

  November 13, 2025

   · 

  4 min read
• Press Releases

  Sitryx presents new preclinical data highlighting PKM2 as a promising metabolic target for the treatment of atopic dermatitis at the Inflammatory Disease Skin Summit 2025

  November 13, 2025

   · 

  3 min read
• Press Releases

  PepGen Announces Issuance of U.S. Patent for Proprietary PGN-EDODM1 Molecule

  November 13, 2025

   · 

  5 min read